Holen Sie sich die Stockscreener-App
0.3178
1.21%
0.0038
Handel nachbörslich:
.31
-0.0078
-2.45%
Schlusskurs vom Vortag:
$0.314
Offen:
$0.314
24-Stunden-Volumen:
137.40K
Relative Volume:
0.17
Marktkapitalisierung:
$3.35M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.26M
KGV:
-0.0545
EPS:
-5.83
Netto-Cashflow:
$-8.25M
1W Leistung:
-0.03%
1M Leistung:
-24.33%
6M Leistung:
-70.30%
1J Leistung:
-91.61%
1-Tages-Spanne:
$0.31
$0.3294
1-Wochen-Bereich:
$0.28
$0.3298
52-Wochen-Spanne:
$0.28
$7.74
Oragenics Inc Stock (OGEN) Company Profile
Firmenname
Oragenics Inc
Sektor
Branche
Telefon
813-286-7900
Adresse
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Oragenics Inc Aktie (OGEN) Neueste Nachrichten
StockNews.com Initiates Coverage on Oragenics (NYSE:OGEN) - Defense World
SEC Form DEF 14A filed by Oragenics Inc. - Quantisnow
OGEN stock plunges to 52-week low, touches $0.28 By Investing.com - Investing.com Canada
OGEN stock plunges to 52-week low, touches $0.28 - Investing.com
Oragenics (NYSE:OGEN) Now Covered by Analysts at StockNews.com - Defense World
Oragenics, Inc. to Present at the Centurion One Capital 2nd Annual Bahamas Summit - Marketscreener.com
Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit - GlobeNewswire
Check Out Oragenics Inc (OGEN)’s Trade Data Rather Than the Analysts’ Views - SETE News
Oragenics Shares Investor Presentation Online - TipRanks
Oragenics inks sales agreement for at-the-market stock offering - Investing.com
Oragenics inks sales agreement for at-the-market stock offering By Investing.com - Investing.com South Africa
Oragenics Inc (OGEN) stock analysis: A comprehensive overview - US Post News
The Future of Oragenics Inc: Analyzing OGEN - The InvestChronicle
Oragenics advances concussion treatment with ONP-002 By Investing.com - Investing.com South Africa
Oragenics advances concussion treatment with ONP-002 - Investing.com India
Metric Deep Dive: Understanding Oragenics Inc (OGEN) Through its Ratios - The Dwinnex
Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation - GlobeNewswire
OGEN stock touches 52-week low at $0.37 amid sharp annual decline - Investing.com India
OGEN’s valuation metrics: A comprehensive analysis - US Post News
Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002 - The Manila Times
EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate - Yahoo Finance
Naples Soap Company Announces Reverse Stock Split - Business Wire
CDE STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Coeur Mining, Inc. Is Fair to Shareholders - Business Wire
Ferguson Files Form 8-K and Prospectus Supplement to its Shelf Registration Statement - Business Wire
Photo of Genesco Employees Fitting Students with New Shoes at Ida B. Wells Elementary School in Nashville Available on Business Wire's Website and the Associated Press Photo Network - Business Wire
Webcast Alert: Olympic Steel to Announce Third-Quarter 2024 Financial Results After Market Closes on October 31, 2024 - Business Wire
Reinsurance Group of America Announces Third Quarter Earnings Release Date, Webcast - Business Wire
Graco Inc. Announces Third Quarter 2024 Earnings Conference Call - Business Wire
Momentive Technologies Acquires Spherical Alumina and Spherical Silica Businesses From Sibelco - Business Wire
Wellfit Technologies to Share Expert Insights on AADOM Radio: Demystifying Dental Financing for Profitability - Business Wire
OGEN stock touches 52-week low at $0.38 amid sharp annual decline By Investing.com - Investing.com South Africa
OGEN stock touches 52-week low at $0.38 amid sharp annual decline - Investing.com
Toyoda Gosei Invests in TriOrb Inc., a Startup Developing Mobile Robots With Omnidirectional Movement Capability - Business Wire
LLAP Investors Have Opportunity to Lead Terran Orbital Corporation Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
Oragenics (AMEX:OGEN) Stock Quotes, Forecast and News Summary - Benzinga
Afya Limited to Host Afya Day 2024 on October 29th | Hybrid Event - Business Wire
Expliseat Unveils an Ultra-Light Train Seat at Innotrans - Business Wire
OGEN stock touches 52-week low at $0.47 amid sharp annual decline - Investing.com India
Oragenics grants stock options to top executives - Investing.com India
Oragenics grants stock options to top executives By Investing.com - Investing.com Canada
Oragenics Executive Compensation and Shareholder Meeting Updates - TipRanks
OutKick Delivers Strong Year Over Year Growth in August 2024 - Business Wire
Oragenics Inc’s Market Journey: Closing Weak at 0.50, Down -6.08 - The Dwinnex
Sopra Steria Group: Disclosure of the Total Number of Shares and Voting Rights as at 31 August 2024 - Business Wire
Deeper Dive: Understanding Oragenics Inc (OGEN) Through its Various Ratios - The Dwinnex
Holdings of Oragenics Inc (OGEN) are aligned with the stars - SETE News
OGEN stock touches 52-week low at $0.47 amid sharp yearly decline - Investing.com
Finanzdaten der Oragenics Inc-Aktie (OGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):